KORU Medical Systems, Inc. (KRMD)
USD 3.7
(-10.19%)
USD 3.7
(-10.19%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -9.39 Million USD | 7.43% |
| 2022 | -10.19 Million USD | -55.29% |
| 2021 | -6.56 Million USD | -261.84% |
| 2020 | 1.61 Million USD | -47.72% |
| 2019 | 4.34 Million USD | 135.05% |
| 2018 | 2.37 Million USD | 83.4% |
| 2017 | 1.87 Million USD | 514.27% |
| 2016 | -474.2 Thousand USD | -129.97% |
| 2015 | 1.41 Million USD | 0.48% |
| 2014 | 1.35 Million USD | 15.13% |
| 2013 | 1.24 Million USD | -1.06% |
| 2012 | 1.25 Million USD | -10.28% |
| 2011 | 1.41 Million USD | 8.34% |
| 2010 | 1.29 Million USD | 64.76% |
| 2009 | 774.76 Thousand USD | -8.24% |
| 2008 | 855.89 Thousand USD | 227.99% |
| 2007 | 261.7 Thousand USD | 22.87% |
| 2006 | 38.29 Thousand USD | 168.31% |
| 2005 | -9164.00 USD | 128.6% |
| 2004 | -277.53 Thousand USD | -144.01% |
| 2003 | -165.09 Thousand USD | 33.53% |
| 2002 | -171.12 Thousand USD | 31.12% |
| 2001 | -289.42 Thousand USD | -314.86% |
| 2000 | -17.38 Thousand USD | 121.16% |
| 1999 | -149.54 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -974.17 Thousand USD | 43.69% |
| 2024 Q1 | -1.73 Million USD | 12.15% |
| 2023 FY | - USD | 7.43% |
| 2023 Q3 | -1.56 Million USD | 48.09% |
| 2023 Q2 | -3 Million USD | -7.98% |
| 2023 Q4 | -1.96 Million USD | -26.06% |
| 2023 Q1 | -2.78 Million USD | -19.97% |
| 2022 Q4 | -2.32 Million USD | -71.41% |
| 2022 Q2 | -3.46 Million USD | -15.14% |
| 2022 Q3 | -1.35 Million USD | 60.9% |
| 2022 Q1 | -3.01 Million USD | -51.06% |
| 2022 FY | - USD | -55.29% |
| 2021 FY | - USD | -261.84% |
| 2021 Q1 | -2.08 Million USD | -97.35% |
| 2021 Q2 | -1.26 Million USD | 39.32% |
| 2021 Q4 | -1.99 Million USD | -66.18% |
| 2021 Q3 | -1.19 Million USD | 5.13% |
| 2020 FY | - USD | -47.72% |
| 2020 Q3 | 451.77 Thousand USD | -67.96% |
| 2020 Q4 | -1.05 Million USD | -333.61% |
| 2020 Q1 | 680.54 Thousand USD | -62.1% |
| 2020 Q2 | 1.4 Million USD | 107.17% |
| 2019 Q4 | 1.79 Million USD | -32.1% |
| 2019 FY | - USD | 135.05% |
| 2019 Q3 | 2.64 Million USD | 13.84% |
| 2019 Q2 | 2.32 Million USD | 141.1% |
| 2019 Q1 | 963.57 Thousand USD | 374.92% |
| 2018 Q3 | 1.13 Million USD | 59.06% |
| 2018 FY | - USD | 83.4% |
| 2018 Q4 | -350.49 Thousand USD | -130.91% |
| 2018 Q1 | 566.28 Thousand USD | -26.89% |
| 2018 Q2 | 712.82 Thousand USD | 25.88% |
| 2017 Q4 | 774.59 Thousand USD | 68.58% |
| 2017 Q2 | 232.45 Thousand USD | 485.29% |
| 2017 Q1 | -60.33 Thousand USD | -109.77% |
| 2017 FY | - USD | 514.27% |
| 2017 Q3 | 459.47 Thousand USD | 97.66% |
| 2016 FY | - USD | -129.97% |
| 2016 Q1 | 518.47 Thousand USD | 43.85% |
| 2016 Q4 | -28.76 Thousand USD | 26.95% |
| 2016 Q3 | -39.37 Thousand USD | 87.5% |
| 2016 Q2 | -315.07 Thousand USD | -160.77% |
| 2015 Q4 | 360.41 Thousand USD | -37.46% |
| 2015 Q3 | 576.28 Thousand USD | 10319.09% |
| 2015 Q2 | 5531.00 USD | -98.97% |
| 2015 Q1 | 536.01 Thousand USD | 158.79% |
| 2015 FY | - USD | 0.48% |
| 2014 Q3 | 391.76 Thousand USD | 31.05% |
| 2014 Q4 | 207.12 Thousand USD | -47.13% |
| 2014 FY | - USD | 15.13% |
| 2014 Q1 | 570.65 Thousand USD | 90.37% |
| 2014 Q2 | 298.94 Thousand USD | -47.61% |
| 2013 Q4 | 299.75 Thousand USD | 53.28% |
| 2013 Q2 | 182.08 Thousand USD | -47.3% |
| 2013 FY | - USD | -1.06% |
| 2013 Q1 | 345.49 Thousand USD | 144.25% |
| 2013 Q3 | 195.55 Thousand USD | 7.4% |
| 2012 Q2 | 188.39 Thousand USD | -60.34% |
| 2012 Q4 | 141.45 Thousand USD | -75.87% |
| 2012 Q3 | 586.12 Thousand USD | 211.12% |
| 2012 FY | - USD | -10.28% |
| 2012 Q1 | 475.02 Thousand USD | 38.29% |
| 2011 FY | - USD | 8.34% |
| 2011 Q1 | 583.26 Thousand USD | 89.68% |
| 2011 Q2 | 359.72 Thousand USD | -38.33% |
| 2011 Q3 | 227.74 Thousand USD | -36.69% |
| 2011 Q4 | 343.49 Thousand USD | 50.82% |
| 2010 Q2 | 151.92 Thousand USD | -54.8% |
| 2010 FY | - USD | 64.76% |
| 2010 Q4 | 307.5 Thousand USD | 55.15% |
| 2010 Q1 | 336.15 Thousand USD | 170.84% |
| 2010 Q3 | 198.19 Thousand USD | 30.46% |
| 2009 Q4 | 124.11 Thousand USD | -41.01% |
| 2009 FY | - USD | -8.24% |
| 2009 Q1 | 221.63 Thousand USD | 0.91% |
| 2009 Q3 | 210.38 Thousand USD | 79.8% |
| 2009 Q2 | 117.01 Thousand USD | -47.2% |
| 2008 Q2 | 94.54 Thousand USD | -40.67% |
| 2008 Q1 | 159.35 Thousand USD | 64.29% |
| 2008 FY | - USD | 227.99% |
| 2008 Q4 | 219.63 Thousand USD | -31.41% |
| 2008 Q3 | 320.22 Thousand USD | 238.7% |
| 2007 FY | - USD | 22.87% |
| 2007 Q3 | 85.8 Thousand USD | 210.79% |
| 2007 Q4 | 96.99 Thousand USD | 13.04% |
| 2007 Q2 | -77.44 Thousand USD | -204.27% |
| 2007 Q1 | 74.27 Thousand USD | -43.05% |
| 2006 Q1 | -91.71 Thousand USD | -181.54% |
| 2006 Q3 | 45.58 Thousand USD | 146.24% |
| 2006 Q4 | 130.43 Thousand USD | 186.14% |
| 2006 FY | - USD | 168.31% |
| 2006 Q2 | -98.58 Thousand USD | -7.49% |
| 2005 Q2 | -109.66 Thousand USD | 28.76% |
| 2005 FY | - USD | 128.6% |
| 2005 Q4 | 112.48 Thousand USD | 2894.61% |
| 2005 Q3 | -4025.00 USD | 96.33% |
| 2005 Q1 | -153.94 Thousand USD | -65.58% |
| 2004 FY | - USD | -144.01% |
| 2004 Q2 | 33.02 Thousand USD | 144.0% |
| 2004 Q3 | -63.64 Thousand USD | -292.71% |
| 2004 Q4 | -92.97 Thousand USD | -46.09% |
| 2004 Q1 | -75.05 Thousand USD | -62.16% |
| 2003 Q1 | -133.54 Thousand USD | -877.15% |
| 2003 FY | - USD | 33.53% |
| 2003 Q4 | -46.28 Thousand USD | -5.2% |
| 2003 Q3 | -43.99 Thousand USD | -18662.45% |
| 2003 Q2 | 237.00 USD | 100.18% |
| 2002 FY | - USD | 31.12% |
| 2002 Q4 | -13.66 Thousand USD | -270.84% |
| 2002 Q3 | 8000.00 USD | 130.77% |
| 2002 Q2 | -25.99 Thousand USD | 70.17% |
| 2002 Q1 | -87.15 Thousand USD | -17.14% |
| 2001 Q1 | -101.26 Thousand USD | -1823.4% |
| 2001 FY | - USD | -314.86% |
| 2001 Q4 | -74.4 Thousand USD | -82.19% |
| 2001 Q3 | -40.83 Thousand USD | 53.07% |
| 2001 Q2 | -87.02 Thousand USD | 14.06% |
| 2000 FY | - USD | 121.16% |
| 2000 Q2 | 31.41 Thousand USD | 0.0% |
| 2000 Q4 | 5876.00 USD | -87.39% |
| 2000 Q3 | 46.59 Thousand USD | 48.31% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 79.401% |
| AngioDynamics, Inc. | -14.29 Million USD | 34.232% |
| AtriCure, Inc. | -8.1 Million USD | -15.916% |
| Avinger, Inc. | -16.34 Million USD | 42.496% |
| Azenta, Inc. | 55.15 Million USD | 117.043% |
| BioLife Solutions, Inc. | -45.23 Million USD | 79.222% |
| The Cooper Companies, Inc. | 882.8 Million USD | 101.065% |
| Daxor Corporation | 329.74 Thousand USD | 2950.606% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 28.78% |
| Femasys Inc. | -13.16 Million USD | 28.626% |
| GlucoTrack, Inc. | -7.09 Million USD | -32.557% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 199.016% |
| Hologic, Inc. | 1.29 Billion USD | 100.725% |
| ICU Medical, Inc. | 307.69 Million USD | 103.055% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 100.393% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 119.187% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -42.957% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -42.957% |
| Masimo Corporation | 236.7 Million USD | 103.971% |
| Microbot Medical Inc. | -10.63 Million USD | 11.608% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 159.602% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 104.061% |
| Nephros, Inc. | -1.37 Million USD | -581.624% |
| NovoCure Limited | -175.86 Million USD | 94.655% |
| NEXGEL, Inc. | -2.73 Million USD | -244.307% |
| NEXGEL, Inc. | -2.73 Million USD | -244.307% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 89.133% |
| OraSure Technologies, Inc. | 76.15 Million USD | 112.342% |
| Pro-Dex, Inc. | 8.33 Million USD | 212.8% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 77.814% |
| Predictive Oncology Inc. | -13.18 Million USD | 28.694% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | -274.195% |
| QuidelOrtho Corporation | 545.6 Million USD | 101.723% |
| Repligen Corporation | 124.29 Million USD | 107.563% |
| Sanara MedTech Inc. | -289.09 Thousand USD | -3151.362% |
| STAAR Surgical Company | 33.22 Million USD | 128.294% |
| Sharps Technology, Inc. | -8.98 Million USD | -4.668% |
| Utah Medical Products, Inc. | 24.8 Million USD | 137.894% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 104.052% |
| Jin Medical International Ltd. | 3.44 Million USD | 373.015% |